These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11786762)

  • 41. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA; Herdman CR
    Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
    Martorana G; Casà A; Oliva L; Orlando A; Cottone M
    Recenti Prog Med; 2001; 92(7-8):451-5. PubMed ID: 11475786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
    Yarur AJ; Kanagala V; Stein DJ; Czul F; Quintero MA; Agrawal D; Patel A; Best K; Fox C; Idstein K; Abreu MT
    Aliment Pharmacol Ther; 2017 Apr; 45(7):933-940. PubMed ID: 28211593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease.
    Yang BL; Chen YG; Gu YF; Chen HJ; Sun GD; Zhu P; Shao WJ
    World J Gastroenterol; 2015 Feb; 21(8):2475-82. PubMed ID: 25741157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice.
    Cadahia V; García-Carbonero A; Vivas S; Fuentes D; Niño P; Rebollo P; Rodrigo L
    Rev Esp Enferm Dig; 2004 Jun; 96(6):369-74; 374-8. PubMed ID: 15230666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenocarcinoma associated with perianal fistulas in Crohn's disease.
    Ogawa H; Haneda S; Shibata C; Miura K; Nagao M; Ohnuma S; Kohyama A; Unno M
    Anticancer Res; 2013 Feb; 33(2):685-9. PubMed ID: 23393368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
    El-Gazzaz G; Hull T; Church JM
    Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimized timing of using infliximab in perianal fistulizing Crohn's disease.
    Sun XL; Chen SY; Tao SS; Qiao LC; Chen HJ; Yang BL
    World J Gastroenterol; 2020 Apr; 26(14):1554-1563. PubMed ID: 32327905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anal Fistulas in Severe Perineal Crohn's Disease: Mri Assessment in the Determination of Long-Term Healing Rates.
    Brochard C; Landemaine A; L'Heritier AM; Dewitte MP; Tchoundjeu B; Rohou T; Garros A; Bouguen G; Siproudhis L
    Inflamm Bowel Dis; 2018 Jun; 24(7):1612-1618. PubMed ID: 29688401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infliximab for fistulas: a hole in one?
    Korzenik JR
    Inflamm Bowel Dis; 2000 Feb; 6(1):62-3. PubMed ID: 10701153
    [No Abstract]   [Full Text] [Related]  

  • 56. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn's disease.
    Chambaz M; Verdalle-Cazes M; Desprez C; Thomassin L; Charpentier C; Grigioni S; Armengol-Debeir L; Bridoux V; Savoye G; Savoye-Collet C
    Dig Liver Dis; 2019 Mar; 51(3):358-363. PubMed ID: 30612820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
    Orlando A; Colombo E; Kohn A; Biancone L; Rizzello F; Viscido A; Sostegni R; Benazzato L; Castiglione F; Papi C; Meucci G; Riegler G; Mocciaro F; Cassinotti A; Cosintino R; Geremia A; Morselli C; Angelucci E; Lavagna A; Rispo A; Bossa F; Scimeca D; Cottone M;
    Dig Liver Dis; 2005 Aug; 37(8):577-83. PubMed ID: 15886081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical experience with the use of infliximab in 44 patients with Crohn's disease].
    Steinwurz F
    Arq Gastroenterol; 2003; 40(3):198-200. PubMed ID: 15029398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
    Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
    Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.